Acro Biomedical (ACBM) Long-Term Debt Issuances (2017 - 2025)
Acro Biomedical (ACBM) has 9 years of Long-Term Debt Issuances data on record, last reported at $25152.0 in Q4 2025.
- For Q4 2025, Long-Term Debt Issuances rose 144.43% year-over-year to $25152.0; the TTM value through Dec 2025 reached $199924.0, up 443.39%, while the annual FY2025 figure was $199924.0, 443.39% up from the prior year.
- Long-Term Debt Issuances reached $25152.0 in Q4 2025 per ACBM's latest filing, down from $58707.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $93759.0 in Q2 2025 and bottomed at $36.0 in Q1 2023.
- Average Long-Term Debt Issuances over 5 years is $16220.6, with a median of $6607.0 recorded in 2024.
- Peak YoY movement for Long-Term Debt Issuances: tumbled 99.81% in 2023, then soared 36811.11% in 2024.
- A 5-year view of Long-Term Debt Issuances shows it stood at $1091.0 in 2021, then crashed by 78.74% to $232.0 in 2022, then skyrocketed by 4088.79% to $9718.0 in 2023, then increased by 5.89% to $10290.0 in 2024, then skyrocketed by 144.43% to $25152.0 in 2025.
- Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $25152.0 in Q4 2025, $58707.0 in Q3 2025, and $93759.0 in Q2 2025.